
TransMedics Group Inc (TMDX)
US$ 123.341.67%
Price Chart
Key Statistics
Market Cap
$ 3.72B
P/E Ratio
77.44
Revenue (TTM)
$ 488.23M
Volume
737.72K
52W High
$ 177.37
52W Low
$ 55.00
Dividend Yield
0.00%
Beta
2.05
Technicals
50-Day MA
125.9686
200-Day MA
92.4564
52 Week High
177.37
52 Week Low
55
About TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
Employees
728
Headquarters
Andover, MA
CEO
Dr. Waleed H. Hassanein M.D.
Latest News
TransMedics Group (TMDX) to Release Quarterly Earnings on Wednesday - MarketBeat
17 hours ago • Google News
Is TMDX a good long term investment - Free Investment Community - Autocar Professional
4 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg